INSTGRA AND TAFERO EM 12 MONTHS Drug profile of Instgra Tafero EM 12 months tablets Instgra Tafero EM tablet are used for treatment involved in HIV-1 infections. Instgra tablets are containing Dolutegravir as an active component; whereas Tafero EM tablets are containing Tenofovir Alafenamide & Emtricitabine as active ingredients. Instgra is pharmacologically classified as an integrase inhibitor. Tafero EM is pharmacologically classified as nucleoside reverse transcriptase inhibitor. This Instgra Tafero EM combination is approved by FDA, which may provide better activity against HIV-1 infections. Instgra Tafero EM should not have capability of curing the HIV infection, but it can able to reduce the development of HIV-1 further to AIDS. This is a fixed dose combination of one Integrase inhibitor with two nucleoside reverse transcriptase inhibitors. PRODUCT DETAILS Brand name: Instgra Tafero EM 12 months tab...